VILLARD acquired by YOTTA CAPITAL
Context
Yotta Capital Partners led a majority buyout of Villard, succeeding the previous sponsorless structure held by CEO. The transaction values the company on a solid growth trajectory, with the management team and historical regional partners reinvesting in the new pool. This primary investment for Yotta's second fund aims to triple Villard's size by 2030 through organic growth and a proactive "buy-and-build" strategy, focusing on expanding the product range in medical logistics and increasing international sales beyond the current 20%.
VILLARD, which reported an EBITDA margin of [members only] in 2025, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Villard is a premier French manufacturer of medical furniture and logistics solutions for healthcare institutions. The company specializes in high-quality medical carts, examination furniture, and hygiene-related equipment designed for hospitals, clinics, and retirement homes. Villard is recognized for its Corporate agility, mastering the transformation of steel, stainless steel, and composite materials to provide ergonomic and durable equipment.
Ent. Value
€10–30M
Equity Value
[members only]
Multiples
EV / Revenue
[members only]
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (EUR)
Similar deals in Life Sciences
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 02/2026 | IMA GROUP | PROSYS | IRELAND | Medical Devices |
| 02/2026 | NORD HOLDING | HALLMARQ VETERINARY IMAGING | UNITED KINGDOM | Diagnostic Equipment |
| 01/2026 | ARDIAN | IVB Wellness Lab | SPAIN | Nutrition & Dietary Supplements |
| 01/2026 | FAGRON | UNIVERSITY COMPOUNDING PHARMACY (UCP) | UNITED STATES | Compounding |
| 12/2025 | CHARTERHOUSE | WINBACK | FRANCE | Medical Devices |
| 12/2025 | MONTAGU PRIVATE EQUITY / Kohlberg | Teleflex Medical OEM | UNITED STATES | Medical Consumables |
| 11/2025 | PFIZER | METSERA | UNITED STATES | R&D Biotech |
| 11/2025 | ANJAC BEAUTY & HEALTH | HEALTH CHAIN GROUP (HCG) | SLOVENIA | CDMO |
| 11/2025 | ARLANE | DESSINTEY | FRANCE | Medical Devices |
| 10/2025 | PUBLIC MARKETS (IPO) | OTTOBOCK | GERMANY | Implants & Prosthetics |
Other operations with YOTTA CAPITAL
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 07/2026 | YOTTA CAPITAL / OUEST CROISSANCE | Les Laboratoires Herbolistique | FRANCE | Nutrition & Dietary Supplements |
REFERENCES
Revenue range: €10–30M
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of VILLARD by YOTTA CAPITAL are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: yotta capital